Quantification Of Plasma Phosphorylated Tau To Use As A Biomarker For Brain Alzheimer Pathology: Pilot Case-control Studies Including Patients With Alzheimer’s Disease And Down Syndrome
…for less invasive and lower-cost blood-based biomarkers to detect brain Alzheimer’s disease (AD) pathology. This study is aimed to determine whether quantification of plasma tau phosphorylated at threonine 181 (p-tau181)…
read more